nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—Peptide GPCRs—MC1R—skin cancer	0.013	0.0441	CbGpPWpGaD
Octreotide—SSTR4—female reproductive system—skin cancer	0.011	0.149	CbGeAlD
Octreotide—SSTR3—Peptide GPCRs—MC1R—skin cancer	0.00982	0.0334	CbGpPWpGaD
Octreotide—SSTR1—Peptide GPCRs—MC1R—skin cancer	0.00941	0.0321	CbGpPWpGaD
Octreotide—SSTR4—head—skin cancer	0.0092	0.125	CbGeAlD
Octreotide—SSTR5—Peptide GPCRs—MC1R—skin cancer	0.00835	0.0284	CbGpPWpGaD
Octreotide—SSTR2—Peptide GPCRs—MC1R—skin cancer	0.0077	0.0262	CbGpPWpGaD
Octreotide—SSTR3—head—skin cancer	0.0075	0.102	CbGeAlD
Octreotide—SSTR1—female reproductive system—skin cancer	0.0071	0.0962	CbGeAlD
Octreotide—MPO—endothelium—skin cancer	0.00685	0.0929	CbGeAlD
Octreotide—MPO—blood vessel—skin cancer	0.00632	0.0856	CbGeAlD
Octreotide—SSTR4—Peptide ligand-binding receptors—MC1R—skin cancer	0.00609	0.0207	CbGpPWpGaD
Octreotide—SSTR1—head—skin cancer	0.00593	0.0803	CbGeAlD
Octreotide—SSTR2—head—skin cancer	0.00504	0.0683	CbGeAlD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00477	0.0162	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—MC1R—skin cancer	0.00462	0.0157	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—MC1R—skin cancer	0.00443	0.0151	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Other—SMO—skin cancer	0.00441	0.015	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTCH2—skin cancer	0.0043	0.0147	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00409	0.0139	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—MC1R—skin cancer	0.00393	0.0134	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—MC1R—skin cancer	0.00362	0.0123	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00361	0.0123	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00347	0.0118	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTCH2—skin cancer	0.00326	0.0111	CbGpPWpGaD
Octreotide—MPO—connective tissue—skin cancer	0.00324	0.0439	CbGeAlD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00314	0.0107	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTCH2—skin cancer	0.00313	0.0107	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—MC1R—skin cancer	0.00311	0.0106	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.0031	0.0105	CbGpPWpGaD
Octreotide—MPO—epithelium—skin cancer	0.00308	0.0417	CbGeAlD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00307	0.0105	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00297	0.0101	CbGpPWpGaD
Octreotide—MPO—skin of body—skin cancer	0.00293	0.0396	CbGeAlD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00284	0.00966	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTCH2—skin cancer	0.00277	0.00945	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00269	0.00915	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RHOU—skin cancer	0.00267	0.0091	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00263	0.00897	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTCH2—skin cancer	0.00256	0.00872	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00243	0.00828	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00238	0.0081	CbGpPWpGaD
Octreotide—MPO—lymphoid tissue—skin cancer	0.00237	0.0321	CbGeAlD
Octreotide—SSTR3—GPCR ligand binding—MC1R—skin cancer	0.00236	0.00803	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00228	0.00776	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—MC1R—skin cancer	0.00226	0.0077	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—SHH—skin cancer	0.00222	0.00755	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTCH2—skin cancer	0.00221	0.00752	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—SMO—skin cancer	0.0021	0.00716	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTCH1—skin cancer	0.0021	0.00716	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTGER4—skin cancer	0.00205	0.00697	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00204	0.00694	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RHOU—skin cancer	0.00202	0.0069	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00202	0.00688	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—MC1R—skin cancer	0.00201	0.00683	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00195	0.00665	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RHOU—skin cancer	0.00194	0.00661	CbGpPWpGaD
Octreotide—MPO—head—skin cancer	0.00191	0.0259	CbGeAlD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00187	0.00635	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—MC1R—skin cancer	0.00185	0.0063	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—MC1R—skin cancer	0.00176	0.00599	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00173	0.0059	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RHOU—skin cancer	0.00172	0.00586	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—SHH—skin cancer	0.00168	0.00572	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTCH2—skin cancer	0.00167	0.0057	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—SHH—skin cancer	0.00161	0.00549	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTCH2—skin cancer	0.0016	0.00547	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.0016	0.00544	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MC1R—skin cancer	0.0016	0.00544	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTCH1—skin cancer	0.00159	0.00543	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—SMO—skin cancer	0.00159	0.00543	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RHOU—skin cancer	0.00159	0.00541	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTGER4—skin cancer	0.00155	0.00528	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—SMO—skin cancer	0.00153	0.0052	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTCH1—skin cancer	0.00153	0.0052	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTGER4—skin cancer	0.00149	0.00506	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—SHH—skin cancer	0.00143	0.00487	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTCH2—skin cancer	0.00142	0.00485	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTCH1—skin cancer	0.00135	0.00461	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—SMO—skin cancer	0.00135	0.00461	CbGpPWpGaD
Octreotide—MPO—lymph node—skin cancer	0.00134	0.0181	CbGeAlD
Octreotide—SSTR3—GPCR downstream signaling—MC1R—skin cancer	0.00133	0.00454	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTGER4—skin cancer	0.00132	0.00449	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SHH—skin cancer	0.00132	0.00449	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTCH2—skin cancer	0.00131	0.00447	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTCH2—skin cancer	0.0013	0.00444	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—MC1R—skin cancer	0.00128	0.00435	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTCH1—skin cancer	0.00125	0.00426	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SMO—skin cancer	0.00125	0.00426	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CDKN2A—skin cancer	0.00124	0.00421	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTGER4—skin cancer	0.00122	0.00414	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL6—skin cancer	0.00121	0.00413	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MC1R—skin cancer	0.00121	0.00412	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MC1R—skin cancer	0.00116	0.00395	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—skin cancer	0.00116	0.00394	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PTGER4—skin cancer	0.00116	0.00394	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SHH—skin cancer	0.00114	0.00388	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—MC1R—skin cancer	0.00113	0.00386	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—skin cancer	0.00111	0.00379	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTCH1—skin cancer	0.00108	0.00367	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SMO—skin cancer	0.00108	0.00367	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTGER4—skin cancer	0.00105	0.00358	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—MC1R—skin cancer	0.00105	0.00356	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MC1R—skin cancer	0.00103	0.0035	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTCH2—skin cancer	0.000989	0.00337	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GLI2—skin cancer	0.000989	0.00337	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MC1R—skin cancer	0.00095	0.00323	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTCH2—skin cancer	0.000948	0.00323	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MC1R—skin cancer	0.000943	0.00321	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IL6—skin cancer	0.000939	0.0032	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GLI1—skin cancer	0.00093	0.00317	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—NRAS—skin cancer	0.0009	0.00306	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SUFU—skin cancer	0.000881	0.003	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PTGER4—skin cancer	0.000876	0.00298	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—SHH—skin cancer	0.000862	0.00294	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTCH2—skin cancer	0.000841	0.00286	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTGER4—skin cancer	0.00084	0.00286	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—skin cancer	0.000835	0.00284	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—SHH—skin cancer	0.000827	0.00282	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTCH1—skin cancer	0.000818	0.00278	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—SMO—skin cancer	0.000818	0.00278	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTGER4—skin cancer	0.000796	0.00271	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTCH1—skin cancer	0.000784	0.00267	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—SMO—skin cancer	0.000784	0.00267	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTCH2—skin cancer	0.000776	0.00264	CbGpPWpGaD
Octreotide—Sinusitis—Fluorouracil—skin cancer	0.000776	0.00123	CcSEcCtD
Octreotide—Erythema—Dactinomycin—skin cancer	0.000775	0.00123	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000775	0.00122	CcSEcCtD
Octreotide—Pain in extremity—Docetaxel—skin cancer	0.000775	0.00122	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—KRAS—skin cancer	0.000774	0.00264	CbGpPWpGaD
Octreotide—Ill-defined disorder—Bleomycin—skin cancer	0.000771	0.00122	CcSEcCtD
Octreotide—Anaemia—Bleomycin—skin cancer	0.000769	0.00121	CcSEcCtD
Octreotide—Diarrhoea—Vemurafenib—skin cancer	0.000766	0.00121	CcSEcCtD
Octreotide—MPO—Folate Metabolism—IL6—skin cancer	0.000764	0.0026	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTGER4—skin cancer	0.000763	0.0026	CbGpPWpGaD
Octreotide—Urticaria—Imiquimod—skin cancer	0.000759	0.0012	CcSEcCtD
Octreotide—Body temperature increased—Imiquimod—skin cancer	0.000755	0.00119	CcSEcCtD
Octreotide—Abdominal pain—Imiquimod—skin cancer	0.000755	0.00119	CcSEcCtD
Octreotide—Tinnitus—Temozolomide—skin cancer	0.000751	0.00119	CcSEcCtD
Octreotide—Malaise—Bleomycin—skin cancer	0.00075	0.00119	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—GLI2—skin cancer	0.000749	0.00255	CbGpPWpGaD
Octreotide—Flushing—Temozolomide—skin cancer	0.000748	0.00118	CcSEcCtD
Octreotide—Cardiac disorder—Temozolomide—skin cancer	0.000748	0.00118	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PTGER4—skin cancer	0.000745	0.00254	CbGpPWpGaD
Octreotide—Rhinitis—Fluorouracil—skin cancer	0.000744	0.00118	CcSEcCtD
Octreotide—Dizziness—Vemurafenib—skin cancer	0.000741	0.00117	CcSEcCtD
Octreotide—Hypoaesthesia—Fluorouracil—skin cancer	0.000739	0.00117	CcSEcCtD
Octreotide—Pharyngitis—Fluorouracil—skin cancer	0.000737	0.00116	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—SHH—skin cancer	0.000733	0.0025	CbGpPWpGaD
Octreotide—Immune system disorder—Temozolomide—skin cancer	0.000728	0.00115	CcSEcCtD
Octreotide—Cough—Bleomycin—skin cancer	0.000726	0.00115	CcSEcCtD
Octreotide—Dehydration—Docetaxel—skin cancer	0.00072	0.00114	CcSEcCtD
Octreotide—Ill-defined disorder—Dactinomycin—skin cancer	0.00072	0.00114	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—GLI2—skin cancer	0.000719	0.00245	CbGpPWpGaD
Octreotide—Anaemia—Dactinomycin—skin cancer	0.000717	0.00113	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—MC1R—skin cancer	0.000715	0.00243	CbGpPWpGaD
Octreotide—Vomiting—Vemurafenib—skin cancer	0.000712	0.00113	CcSEcCtD
Octreotide—Alopecia—Temozolomide—skin cancer	0.000712	0.00113	CcSEcCtD
Octreotide—Dry skin—Docetaxel—skin cancer	0.00071	0.00112	CcSEcCtD
Octreotide—Myalgia—Bleomycin—skin cancer	0.000708	0.00112	CcSEcCtD
Octreotide—Chest pain—Bleomycin—skin cancer	0.000708	0.00112	CcSEcCtD
Octreotide—Abdominal pain upper—Docetaxel—skin cancer	0.000707	0.00112	CcSEcCtD
Octreotide—Rash—Vemurafenib—skin cancer	0.000706	0.00112	CcSEcCtD
Octreotide—Mental disorder—Temozolomide—skin cancer	0.000706	0.00112	CcSEcCtD
Octreotide—Dermatitis—Vemurafenib—skin cancer	0.000706	0.00112	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—GLI1—skin cancer	0.000705	0.0024	CbGpPWpGaD
Octreotide—Hypersensitivity—Imiquimod—skin cancer	0.000704	0.00111	CcSEcCtD
Octreotide—Headache—Vemurafenib—skin cancer	0.000702	0.00111	CcSEcCtD
Octreotide—Erythema—Temozolomide—skin cancer	0.000701	0.00111	CcSEcCtD
Octreotide—Malnutrition—Temozolomide—skin cancer	0.000701	0.00111	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000701	0.00239	CbGpPWpGaD
Octreotide—Discomfort—Bleomycin—skin cancer	0.000699	0.00111	CcSEcCtD
Octreotide—Malaise—Dactinomycin—skin cancer	0.000699	0.00111	CcSEcCtD
Octreotide—Cramp muscle—Docetaxel—skin cancer	0.000697	0.0011	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—SMO—skin cancer	0.000695	0.00237	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTCH1—skin cancer	0.000695	0.00237	CbGpPWpGaD
Octreotide—Nasopharyngitis—Docetaxel—skin cancer	0.000693	0.00109	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—PTGER4—skin cancer	0.000688	0.00234	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MC1R—skin cancer	0.000685	0.00233	CbGpPWpGaD
Octreotide—Asthenia—Imiquimod—skin cancer	0.000685	0.00108	CcSEcCtD
Octreotide—Oedema—Bleomycin—skin cancer	0.000679	0.00107	CcSEcCtD
Octreotide—Anaphylactic shock—Bleomycin—skin cancer	0.000679	0.00107	CcSEcCtD
Octreotide—Back pain—Temozolomide—skin cancer	0.000678	0.00107	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—SHH—skin cancer	0.000677	0.0023	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTGER4—skin cancer	0.000677	0.0023	CbGpPWpGaD
Octreotide—Pruritus—Imiquimod—skin cancer	0.000676	0.00107	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—GLI1—skin cancer	0.000676	0.0023	CbGpPWpGaD
Octreotide—Infection—Bleomycin—skin cancer	0.000674	0.00107	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SHH—skin cancer	0.000672	0.00229	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RASA1—skin cancer	0.000668	0.00227	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SUFU—skin cancer	0.000668	0.00227	CbGpPWpGaD
Octreotide—Nausea—Vemurafenib—skin cancer	0.000665	0.00105	CcSEcCtD
Octreotide—Thrombocytopenia—Bleomycin—skin cancer	0.000664	0.00105	CcSEcCtD
Octreotide—Arrhythmia—Fluorouracil—skin cancer	0.000663	0.00105	CcSEcCtD
Octreotide—Vision blurred—Temozolomide—skin cancer	0.000661	0.00104	CcSEcCtD
Octreotide—Myalgia—Dactinomycin—skin cancer	0.00066	0.00104	CcSEcCtD
Octreotide—Bronchospasm—Docetaxel—skin cancer	0.000658	0.00104	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—HRAS—skin cancer	0.000658	0.00224	CbGpPWpGaD
Octreotide—Tremor—Temozolomide—skin cancer	0.000657	0.00104	CcSEcCtD
Octreotide—Alopecia—Fluorouracil—skin cancer	0.000656	0.00104	CcSEcCtD
Octreotide—Diarrhoea—Imiquimod—skin cancer	0.000654	0.00103	CcSEcCtD
Octreotide—Discomfort—Dactinomycin—skin cancer	0.000652	0.00103	CcSEcCtD
Octreotide—Ill-defined disorder—Temozolomide—skin cancer	0.000651	0.00103	CcSEcCtD
Octreotide—Anaemia—Temozolomide—skin cancer	0.000648	0.00102	CcSEcCtD
Octreotide—Anorexia—Bleomycin—skin cancer	0.000647	0.00102	CcSEcCtD
Octreotide—Erythema—Fluorouracil—skin cancer	0.000646	0.00102	CcSEcCtD
Octreotide—Agitation—Temozolomide—skin cancer	0.000645	0.00102	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTCH1—skin cancer	0.000642	0.00218	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—SMO—skin cancer	0.000642	0.00218	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SUFU—skin cancer	0.00064	0.00218	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GLI2—skin cancer	0.000637	0.00217	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTCH1—skin cancer	0.000637	0.00217	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SMO—skin cancer	0.000637	0.00217	CbGpPWpGaD
Octreotide—Oedema—Dactinomycin—skin cancer	0.000633	0.001	CcSEcCtD
Octreotide—Malaise—Temozolomide—skin cancer	0.000633	0.001	CcSEcCtD
Octreotide—Dizziness—Imiquimod—skin cancer	0.000632	0.000999	CcSEcCtD
Octreotide—Vertigo—Temozolomide—skin cancer	0.00063	0.000996	CcSEcCtD
Octreotide—Infection—Dactinomycin—skin cancer	0.000629	0.000994	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTGER4—skin cancer	0.000625	0.00213	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTGER4—skin cancer	0.00062	0.00211	CbGpPWpGaD
Octreotide—Palpitations—Temozolomide—skin cancer	0.00062	0.00098	CcSEcCtD
Octreotide—Thrombocytopenia—Dactinomycin—skin cancer	0.00062	0.00098	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000618	0.000977	CcSEcCtD
Octreotide—Cough—Temozolomide—skin cancer	0.000612	0.000968	CcSEcCtD
Octreotide—Paraesthesia—Bleomycin—skin cancer	0.000609	0.000963	CcSEcCtD
Octreotide—Weight increased—Docetaxel—skin cancer	0.000609	0.000963	CcSEcCtD
Octreotide—Vision blurred—Fluorouracil—skin cancer	0.000609	0.000963	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—MC1R—skin cancer	0.000608	0.00207	CbGpPWpGaD
Octreotide—Convulsion—Temozolomide—skin cancer	0.000608	0.000961	CcSEcCtD
Octreotide—Vomiting—Imiquimod—skin cancer	0.000607	0.00096	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—IL6—skin cancer	0.000607	0.00207	CbGpPWpGaD
Octreotide—Weight decreased—Docetaxel—skin cancer	0.000606	0.000957	CcSEcCtD
Octreotide—Hypertension—Temozolomide—skin cancer	0.000606	0.000957	CcSEcCtD
Octreotide—Dyspnoea—Bleomycin—skin cancer	0.000605	0.000956	CcSEcCtD
Octreotide—Anorexia—Dactinomycin—skin cancer	0.000603	0.000954	CcSEcCtD
Octreotide—Rash—Imiquimod—skin cancer	0.000602	0.000952	CcSEcCtD
Octreotide—Dermatitis—Imiquimod—skin cancer	0.000602	0.000951	CcSEcCtD
Octreotide—Pneumonia—Docetaxel—skin cancer	0.0006	0.000949	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GLI1—skin cancer	0.000599	0.00204	CbGpPWpGaD
Octreotide—Headache—Imiquimod—skin cancer	0.000598	0.000946	CcSEcCtD
Octreotide—Anaemia—Fluorouracil—skin cancer	0.000597	0.000944	CcSEcCtD
Octreotide—Arthralgia—Temozolomide—skin cancer	0.000597	0.000944	CcSEcCtD
Octreotide—Myalgia—Temozolomide—skin cancer	0.000597	0.000944	CcSEcCtD
Octreotide—Anxiety—Temozolomide—skin cancer	0.000595	0.000941	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000593	0.000937	CcSEcCtD
Octreotide—Discomfort—Temozolomide—skin cancer	0.00059	0.000933	CcSEcCtD
Octreotide—Decreased appetite—Bleomycin—skin cancer	0.00059	0.000933	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GLI2—skin cancer	0.000588	0.002	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Docetaxel—skin cancer	0.000585	0.000925	CcSEcCtD
Octreotide—Dry mouth—Temozolomide—skin cancer	0.000584	0.000923	CcSEcCtD
Octreotide—Jaundice—Docetaxel—skin cancer	0.000582	0.00092	CcSEcCtD
Octreotide—Pain—Bleomycin—skin cancer	0.00058	0.000917	CcSEcCtD
Octreotide—Conjunctivitis—Docetaxel—skin cancer	0.00058	0.000917	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000577	0.000912	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—skin cancer	0.000574	0.00195	CbGpPWpGaD
Octreotide—Oedema—Temozolomide—skin cancer	0.000572	0.000905	CcSEcCtD
Octreotide—Anaphylactic shock—Temozolomide—skin cancer	0.000572	0.000905	CcSEcCtD
Octreotide—Infection—Temozolomide—skin cancer	0.000569	0.000899	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SUFU—skin cancer	0.000568	0.00193	CbGpPWpGaD
Octreotide—Nausea—Imiquimod—skin cancer	0.000567	0.000897	CcSEcCtD
Octreotide—Hepatobiliary disease—Docetaxel—skin cancer	0.000564	0.000892	CcSEcCtD
Octreotide—Epistaxis—Docetaxel—skin cancer	0.000563	0.00089	CcSEcCtD
Octreotide—Nervous system disorder—Temozolomide—skin cancer	0.000561	0.000887	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—MC1R—skin cancer	0.000561	0.00191	CbGpPWpGaD
Octreotide—Thrombocytopenia—Temozolomide—skin cancer	0.00056	0.000886	CcSEcCtD
Octreotide—Convulsion—Fluorouracil—skin cancer	0.00056	0.000885	CcSEcCtD
Octreotide—Feeling abnormal—Bleomycin—skin cancer	0.000559	0.000884	CcSEcCtD
Octreotide—Skin disorder—Temozolomide—skin cancer	0.000556	0.000879	CcSEcCtD
Octreotide—Hyperhidrosis—Temozolomide—skin cancer	0.000553	0.000875	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GLI1—skin cancer	0.000553	0.00188	CbGpPWpGaD
Octreotide—Myalgia—Fluorouracil—skin cancer	0.00055	0.00087	CcSEcCtD
Octreotide—Chest pain—Fluorouracil—skin cancer	0.00055	0.00087	CcSEcCtD
Octreotide—Decreased appetite—Dactinomycin—skin cancer	0.00055	0.00087	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—FOXO4—skin cancer	0.000548	0.00187	CbGpPWpGaD
Octreotide—Fatigue—Dactinomycin—skin cancer	0.000546	0.000863	CcSEcCtD
Octreotide—Anorexia—Temozolomide—skin cancer	0.000546	0.000863	CcSEcCtD
Octreotide—Discomfort—Fluorouracil—skin cancer	0.000544	0.000859	CcSEcCtD
Octreotide—Pain—Dactinomycin—skin cancer	0.000541	0.000856	CcSEcCtD
Octreotide—Urticaria—Bleomycin—skin cancer	0.000539	0.000852	CcSEcCtD
Octreotide—Rhinitis—Docetaxel—skin cancer	0.000537	0.000849	CcSEcCtD
Octreotide—Body temperature increased—Bleomycin—skin cancer	0.000536	0.000848	CcSEcCtD
Octreotide—Hepatitis—Docetaxel—skin cancer	0.000536	0.000847	CcSEcCtD
Octreotide—Hypoaesthesia—Docetaxel—skin cancer	0.000533	0.000843	CcSEcCtD
Octreotide—Pharyngitis—Docetaxel—skin cancer	0.000532	0.000841	CcSEcCtD
Octreotide—Oedema peripheral—Docetaxel—skin cancer	0.000528	0.000834	CcSEcCtD
Octreotide—Anaphylactic shock—Fluorouracil—skin cancer	0.000527	0.000834	CcSEcCtD
Octreotide—Oedema—Fluorouracil—skin cancer	0.000527	0.000834	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SUFU—skin cancer	0.000524	0.00179	CbGpPWpGaD
Octreotide—Infection—Fluorouracil—skin cancer	0.000524	0.000828	CcSEcCtD
Octreotide—Feeling abnormal—Dactinomycin—skin cancer	0.000522	0.000824	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000522	0.000824	CcSEcCtD
Octreotide—Insomnia—Temozolomide—skin cancer	0.000518	0.000818	CcSEcCtD
Octreotide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000518	0.000818	CcSEcCtD
Octreotide—Nervous system disorder—Fluorouracil—skin cancer	0.000517	0.000818	CcSEcCtD
Octreotide—Thrombocytopenia—Fluorouracil—skin cancer	0.000516	0.000816	CcSEcCtD
Octreotide—Visual impairment—Docetaxel—skin cancer	0.000516	0.000816	CcSEcCtD
Octreotide—Tachycardia—Fluorouracil—skin cancer	0.000515	0.000814	CcSEcCtD
Octreotide—Paraesthesia—Temozolomide—skin cancer	0.000514	0.000813	CcSEcCtD
Octreotide—Dyspnoea—Temozolomide—skin cancer	0.00051	0.000807	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SHH—skin cancer	0.000509	0.00174	CbGpPWpGaD
Octreotide—Somnolence—Temozolomide—skin cancer	0.000509	0.000804	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RASA1—skin cancer	0.000506	0.00172	CbGpPWpGaD
Octreotide—Dyspepsia—Temozolomide—skin cancer	0.000504	0.000797	CcSEcCtD
Octreotide—Anorexia—Fluorouracil—skin cancer	0.000503	0.000795	CcSEcCtD
Octreotide—Abdominal pain—Dactinomycin—skin cancer	0.0005	0.000791	CcSEcCtD
Octreotide—Body temperature increased—Dactinomycin—skin cancer	0.0005	0.000791	CcSEcCtD
Octreotide—Hypersensitivity—Bleomycin—skin cancer	0.0005	0.00079	CcSEcCtD
Octreotide—Decreased appetite—Temozolomide—skin cancer	0.000498	0.000787	CcSEcCtD
Octreotide—Cardiac disorder—Docetaxel—skin cancer	0.000497	0.000786	CcSEcCtD
Octreotide—Flushing—Docetaxel—skin cancer	0.000497	0.000786	CcSEcCtD
Octreotide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000494	0.000781	CcSEcCtD
Octreotide—Fatigue—Temozolomide—skin cancer	0.000494	0.00078	CcSEcCtD
Octreotide—Constipation—Temozolomide—skin cancer	0.00049	0.000774	CcSEcCtD
Octreotide—Pain—Temozolomide—skin cancer	0.00049	0.000774	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SHH—skin cancer	0.000488	0.00166	CbGpPWpGaD
Octreotide—Asthenia—Bleomycin—skin cancer	0.000487	0.00077	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—RASA1—skin cancer	0.000485	0.00165	CbGpPWpGaD
Octreotide—Immune system disorder—Docetaxel—skin cancer	0.000484	0.000765	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SMO—skin cancer	0.000483	0.00164	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTCH1—skin cancer	0.000483	0.00164	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000481	0.00076	CcSEcCtD
Octreotide—Pruritus—Bleomycin—skin cancer	0.00048	0.000759	CcSEcCtD
Octreotide—Arrhythmia—Docetaxel—skin cancer	0.000479	0.000757	CcSEcCtD
Octreotide—Insomnia—Fluorouracil—skin cancer	0.000477	0.000754	CcSEcCtD
Octreotide—Paraesthesia—Fluorouracil—skin cancer	0.000474	0.000749	CcSEcCtD
Octreotide—Alopecia—Docetaxel—skin cancer	0.000473	0.000749	CcSEcCtD
Octreotide—Feeling abnormal—Temozolomide—skin cancer	0.000472	0.000746	CcSEcCtD
Octreotide—Dyspnoea—Fluorouracil—skin cancer	0.00047	0.000743	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PTGER4—skin cancer	0.00047	0.0016	CbGpPWpGaD
Octreotide—Mental disorder—Docetaxel—skin cancer	0.000469	0.000742	CcSEcCtD
Octreotide—Somnolence—Fluorouracil—skin cancer	0.000469	0.000741	CcSEcCtD
Octreotide—Gastrointestinal pain—Temozolomide—skin cancer	0.000468	0.00074	CcSEcCtD
Octreotide—Erythema—Docetaxel—skin cancer	0.000466	0.000737	CcSEcCtD
Octreotide—Malnutrition—Docetaxel—skin cancer	0.000466	0.000737	CcSEcCtD
Octreotide—Hypersensitivity—Dactinomycin—skin cancer	0.000466	0.000737	CcSEcCtD
Octreotide—Dyspepsia—Fluorouracil—skin cancer	0.000464	0.000734	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SMO—skin cancer	0.000463	0.00158	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTCH1—skin cancer	0.000463	0.00158	CbGpPWpGaD
Octreotide—Decreased appetite—Fluorouracil—skin cancer	0.000458	0.000725	CcSEcCtD
Octreotide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000455	0.00072	CcSEcCtD
Octreotide—Urticaria—Temozolomide—skin cancer	0.000455	0.000719	CcSEcCtD
Octreotide—Asthenia—Dactinomycin—skin cancer	0.000454	0.000718	CcSEcCtD
Octreotide—Abdominal pain—Temozolomide—skin cancer	0.000453	0.000715	CcSEcCtD
Octreotide—Body temperature increased—Temozolomide—skin cancer	0.000453	0.000715	CcSEcCtD
Octreotide—Back pain—Docetaxel—skin cancer	0.000451	0.000713	CcSEcCtD
Octreotide—Pain—Fluorouracil—skin cancer	0.000451	0.000713	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTGER4—skin cancer	0.000451	0.00154	CbGpPWpGaD
Octreotide—Muscle spasms—Docetaxel—skin cancer	0.000448	0.000709	CcSEcCtD
Octreotide—Feeling abnormal—Fluorouracil—skin cancer	0.000435	0.000687	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SHH—skin cancer	0.000433	0.00148	CbGpPWpGaD
Octreotide—Diarrhoea—Dactinomycin—skin cancer	0.000433	0.000685	CcSEcCtD
Octreotide—Vomiting—Bleomycin—skin cancer	0.000431	0.000682	CcSEcCtD
Octreotide—Anaemia—Docetaxel—skin cancer	0.000431	0.000682	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—RASA1—skin cancer	0.00043	0.00147	CbGpPWpGaD
Octreotide—Rash—Bleomycin—skin cancer	0.000428	0.000676	CcSEcCtD
Octreotide—Dermatitis—Bleomycin—skin cancer	0.000427	0.000676	CcSEcCtD
Octreotide—Hypersensitivity—Temozolomide—skin cancer	0.000422	0.000667	CcSEcCtD
Octreotide—Urticaria—Fluorouracil—skin cancer	0.000419	0.000662	CcSEcCtD
Octreotide—Syncope—Docetaxel—skin cancer	0.000418	0.000661	CcSEcCtD
Octreotide—Body temperature increased—Fluorouracil—skin cancer	0.000417	0.000659	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FOXO4—skin cancer	0.000415	0.00141	CbGpPWpGaD
Octreotide—Palpitations—Docetaxel—skin cancer	0.000412	0.000652	CcSEcCtD
Octreotide—Asthenia—Temozolomide—skin cancer	0.000411	0.000649	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SMO—skin cancer	0.000411	0.0014	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTCH1—skin cancer	0.000411	0.0014	CbGpPWpGaD
Octreotide—Loss of consciousness—Docetaxel—skin cancer	0.00041	0.000648	CcSEcCtD
Octreotide—Cough—Docetaxel—skin cancer	0.000407	0.000643	CcSEcCtD
Octreotide—Pruritus—Temozolomide—skin cancer	0.000405	0.00064	CcSEcCtD
Octreotide—Convulsion—Docetaxel—skin cancer	0.000404	0.000639	CcSEcCtD
Octreotide—Nausea—Bleomycin—skin cancer	0.000403	0.000637	CcSEcCtD
Octreotide—Hypertension—Docetaxel—skin cancer	0.000403	0.000637	CcSEcCtD
Octreotide—Vomiting—Dactinomycin—skin cancer	0.000402	0.000636	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTGER4—skin cancer	0.0004	0.00136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SHH—skin cancer	0.0004	0.00136	CbGpPWpGaD
Octreotide—Rash—Dactinomycin—skin cancer	0.000399	0.000631	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FOXO4—skin cancer	0.000398	0.00136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RASA1—skin cancer	0.000397	0.00135	CbGpPWpGaD
Octreotide—Chest pain—Docetaxel—skin cancer	0.000397	0.000628	CcSEcCtD
Octreotide—Myalgia—Docetaxel—skin cancer	0.000397	0.000628	CcSEcCtD
Octreotide—Arthralgia—Docetaxel—skin cancer	0.000397	0.000628	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000394	0.000623	CcSEcCtD
Octreotide—Diarrhoea—Temozolomide—skin cancer	0.000392	0.000619	CcSEcCtD
Octreotide—Hypersensitivity—Fluorouracil—skin cancer	0.000389	0.000614	CcSEcCtD
Octreotide—Dry mouth—Docetaxel—skin cancer	0.000388	0.000614	CcSEcCtD
Octreotide—Anaphylactic shock—Docetaxel—skin cancer	0.000381	0.000602	CcSEcCtD
Octreotide—Oedema—Docetaxel—skin cancer	0.000381	0.000602	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SMO—skin cancer	0.000379	0.00129	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTCH1—skin cancer	0.000379	0.00129	CbGpPWpGaD
Octreotide—Dizziness—Temozolomide—skin cancer	0.000379	0.000598	CcSEcCtD
Octreotide—Infection—Docetaxel—skin cancer	0.000378	0.000598	CcSEcCtD
Octreotide—Nausea—Dactinomycin—skin cancer	0.000376	0.000594	CcSEcCtD
Octreotide—Shock—Docetaxel—skin cancer	0.000375	0.000592	CcSEcCtD
Octreotide—Nervous system disorder—Docetaxel—skin cancer	0.000373	0.00059	CcSEcCtD
Octreotide—Pruritus—Fluorouracil—skin cancer	0.000373	0.00059	CcSEcCtD
Octreotide—Thrombocytopenia—Docetaxel—skin cancer	0.000373	0.000589	CcSEcCtD
Octreotide—Tachycardia—Docetaxel—skin cancer	0.000372	0.000587	CcSEcCtD
Octreotide—Skin disorder—Docetaxel—skin cancer	0.00037	0.000585	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTGER4—skin cancer	0.000369	0.00126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TERT—skin cancer	0.000366	0.00125	CbGpPWpGaD
Octreotide—Vomiting—Temozolomide—skin cancer	0.000364	0.000575	CcSEcCtD
Octreotide—Anorexia—Docetaxel—skin cancer	0.000363	0.000574	CcSEcCtD
Octreotide—Rash—Temozolomide—skin cancer	0.000361	0.000571	CcSEcCtD
Octreotide—Diarrhoea—Fluorouracil—skin cancer	0.000361	0.00057	CcSEcCtD
Octreotide—Dermatitis—Temozolomide—skin cancer	0.000361	0.00057	CcSEcCtD
Octreotide—Headache—Temozolomide—skin cancer	0.000359	0.000567	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—FOXO4—skin cancer	0.000353	0.0012	CbGpPWpGaD
Octreotide—Dizziness—Fluorouracil—skin cancer	0.000349	0.000551	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000347	0.000548	CcSEcCtD
Octreotide—Insomnia—Docetaxel—skin cancer	0.000344	0.000544	CcSEcCtD
Octreotide—Paraesthesia—Docetaxel—skin cancer	0.000342	0.00054	CcSEcCtD
Octreotide—Nausea—Temozolomide—skin cancer	0.00034	0.000538	CcSEcCtD
Octreotide—Dyspnoea—Docetaxel—skin cancer	0.000339	0.000537	CcSEcCtD
Octreotide—Somnolence—Docetaxel—skin cancer	0.000338	0.000535	CcSEcCtD
Octreotide—Vomiting—Fluorouracil—skin cancer	0.000335	0.00053	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—skin cancer	0.000335	0.00053	CcSEcCtD
Octreotide—Rash—Fluorouracil—skin cancer	0.000333	0.000526	CcSEcCtD
Octreotide—Dermatitis—Fluorouracil—skin cancer	0.000332	0.000525	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—skin cancer	0.000331	0.000523	CcSEcCtD
Octreotide—Headache—Fluorouracil—skin cancer	0.00033	0.000522	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000329	0.00052	CcSEcCtD
Octreotide—Fatigue—Docetaxel—skin cancer	0.000328	0.000519	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—FOXO4—skin cancer	0.000326	0.00111	CbGpPWpGaD
Octreotide—Constipation—Docetaxel—skin cancer	0.000326	0.000515	CcSEcCtD
Octreotide—Pain—Docetaxel—skin cancer	0.000326	0.000515	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—skin cancer	0.000314	0.000496	CcSEcCtD
Octreotide—Nausea—Fluorouracil—skin cancer	0.000313	0.000495	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—skin cancer	0.000311	0.000492	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—NRAS—skin cancer	0.000308	0.00105	CbGpPWpGaD
Octreotide—Abdominal pain—Docetaxel—skin cancer	0.000301	0.000476	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—skin cancer	0.000301	0.000476	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—BRAF—skin cancer	0.00029	0.000987	CbGpPWpGaD
Octreotide—Hypersensitivity—Docetaxel—skin cancer	0.00028	0.000443	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—TERT—skin cancer	0.000277	0.000945	CbGpPWpGaD
Octreotide—Asthenia—Docetaxel—skin cancer	0.000273	0.000432	CcSEcCtD
Octreotide—Pruritus—Docetaxel—skin cancer	0.000269	0.000426	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TERT—skin cancer	0.000266	0.000906	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—skin cancer	0.000265	0.000904	CbGpPWpGaD
Octreotide—Diarrhoea—Docetaxel—skin cancer	0.00026	0.000412	CcSEcCtD
Octreotide—Dizziness—Docetaxel—skin cancer	0.000252	0.000398	CcSEcCtD
Octreotide—Vomiting—Docetaxel—skin cancer	0.000242	0.000383	CcSEcCtD
Octreotide—Rash—Docetaxel—skin cancer	0.00024	0.000379	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—skin cancer	0.00024	0.000379	CcSEcCtD
Octreotide—Headache—Docetaxel—skin cancer	0.000238	0.000377	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—TERT—skin cancer	0.000236	0.000803	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—skin cancer	0.000234	0.000796	CbGpPWpGaD
Octreotide—Nausea—Docetaxel—skin cancer	0.000226	0.000357	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—HRAS—skin cancer	0.000226	0.000768	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—skin cancer	0.000224	0.000763	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—skin cancer	0.00022	0.000748	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—skin cancer	0.000218	0.000741	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—skin cancer	0.000216	0.000735	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—skin cancer	0.000211	0.000717	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—skin cancer	0.000201	0.000685	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—skin cancer	0.000199	0.000677	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—skin cancer	0.000193	0.000657	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—skin cancer	0.000187	0.000636	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—skin cancer	0.000183	0.000625	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—skin cancer	0.000182	0.00062	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—skin cancer	0.000172	0.000587	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—skin cancer	0.000171	0.000582	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—skin cancer	0.000171	0.000582	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—skin cancer	0.000164	0.000558	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—skin cancer	0.000164	0.000557	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—skin cancer	0.000158	0.000538	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—skin cancer	0.000157	0.000534	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—skin cancer	0.000157	0.000534	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—skin cancer	0.000145	0.000495	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—skin cancer	0.000139	0.000475	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—skin cancer	0.000139	0.000474	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—skin cancer	0.000138	0.00047	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—skin cancer	0.000134	0.000457	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—skin cancer	0.000133	0.000454	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—skin cancer	0.000132	0.000451	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—skin cancer	0.000128	0.000437	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—skin cancer	0.000128	0.000434	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—skin cancer	0.000119	0.000405	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—skin cancer	0.000117	0.0004	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—skin cancer	0.000114	0.000388	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—skin cancer	0.000108	0.000369	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—skin cancer	0.000106	0.00036	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—skin cancer	0.000101	0.000345	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—skin cancer	0.000101	0.000344	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—skin cancer	0.000101	0.000344	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—skin cancer	9.68e-05	0.00033	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—skin cancer	9.67e-05	0.000329	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—skin cancer	9.32e-05	0.000318	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—skin cancer	9.27e-05	0.000316	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—skin cancer	8.98e-05	0.000306	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—skin cancer	8.59e-05	0.000292	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—skin cancer	8.29e-05	0.000282	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—skin cancer	8.22e-05	0.00028	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—skin cancer	7.93e-05	0.00027	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—skin cancer	7.59e-05	0.000258	CbGpPWpGaD
